The Long-term Safety Study of Idursulfase-beta in Hunter Syndrome(Mucopolysaccharidosis II) Patients
NCT02044692
·
clinicaltrials.gov ↗
UNKNOWN
Status
34
Enrollment
INDUSTRY
Sponsor class
Conditions
Hunter Syndrome
Sponsor
Green Cross Corporation